{"id":925380,"date":"2026-01-08T08:57:32","date_gmt":"2026-01-08T13:57:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/"},"modified":"2026-01-08T08:57:32","modified_gmt":"2026-01-08T13:57:32","slug":"klotho-neurosciences-to-present-at-the-biotech-showcase-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/","title":{"rendered":"Klotho Neurosciences to Present at the Biotech Showcase 2026"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">NEW YORK<\/span>, <span class=\"legendSpanClass\">Jan. 8, 2026<\/span> \/PRNewswire\/ &#8212;\u00a0Klotho Neurosciences, Inc. (Nasdaq: KLTO, &#8220;Klotho&#8221;, or &#8220;the Company&#8221;), a U.S.-based biogenetics company, announces that CEO Dr. Joseph Sinkule will be presenting at the 2026 Biotech Showcase in San Francisco on January 13, 2026 at 11:30AM PT.\u00a0 The Biotech Showcase is to be held January 12-14, 2026 at the Hilton San Francisco Union Square.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg\" title=\"Klotho Neurosciences, Inc. logo (PRNewsfoto\/Klotho Neurosciences, Inc.)\" alt=\"Klotho Neurosciences, Inc. logo (PRNewsfoto\/Klotho Neurosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>At the event, the Company will be available for one-on-one meetings with investors and potential partners. To request a meeting, please contact <a href=\"mailto:ir@klothoneurosciences.com\" target=\"_blank\" rel=\"nofollow\">ir@klothoneurosciences.com<\/a>.<\/p>\n<p>\n        <b>About Klotho Neurosciences, Inc.\u00a0\u00a0 <\/b>\n      <\/p>\n<p>Klotho Neurosciences, Inc. (NASDAQ:\u00a0KLTO) is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the &#8220;anti-aging&#8221; human Klotho gene (s-KL), and its novel delivery systems to transform and improve the treatment of neurodegenerative and age-related disorders such as ALS, Alzheimer&#8217;s disease, and Parkinson&#8217;s disease. The Company&#8217;s current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. Klotho is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical product development and commercialization.<\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements. These statements are made under the &#8220;safe harbor&#8221; provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;opportunity,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;will be,&#8221; &#8220;will continue,&#8221; &#8220;will likely result,&#8221; and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company&#8217;s future commercial operations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company&#8217;s inability to implement its business plans, identify and realize additional opportunities, or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the documents filed or to be filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.<\/p>\n<p>\n        <b>Investor Contact and Corporate Communications: <\/b>\n      <\/p>\n<p>Jeffrey LeBlanc, CFO<br \/><a href=\"mailto:ir@klothoneuro.com\" target=\"_blank\" rel=\"nofollow\">ir@klothoneuro.com<\/a><\/p>\n<p>\n        <b>Website: <\/b><br \/>\n        <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4591513-1&amp;h=486801185&amp;u=http%3A%2F%2Fwww.klothoneuro.com%2F&amp;a=www.klothoneuro.com\" target=\"_blank\" rel=\"nofollow\">www.klothoneuro.com<\/a>\n      <\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA58836&amp;sd=2026-01-08\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026-302655910.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026-302655910.html<\/a><\/p>\n<p>SOURCE Klotho Neurosciences, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA58836&amp;Transmission_Id=202601080800PR_NEWS_USPR_____LA58836&amp;DateId=20260108\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, Jan. 8, 2026 \/PRNewswire\/ &#8212;\u00a0Klotho Neurosciences, Inc. (Nasdaq: KLTO, &#8220;Klotho&#8221;, or &#8220;the Company&#8221;), a U.S.-based biogenetics company, announces that CEO Dr. Joseph Sinkule will be presenting at the 2026 Biotech Showcase in San Francisco on January 13, 2026 at 11:30AM PT.\u00a0 The Biotech Showcase is to be held January 12-14, 2026 at the Hilton San Francisco Union Square. At the event, the Company will be available for one-on-one meetings with investors and potential partners. To request a meeting, please contact ir@klothoneurosciences.com. About Klotho Neurosciences, Inc.\u00a0\u00a0 Klotho Neurosciences, Inc. (NASDAQ:\u00a0KLTO) is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the &#8220;anti-aging&#8221; human &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Klotho Neurosciences to Present at the Biotech Showcase 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925380","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Klotho Neurosciences to Present at the Biotech Showcase 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Klotho Neurosciences to Present at the Biotech Showcase 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Jan. 8, 2026 \/PRNewswire\/ &#8212;\u00a0Klotho Neurosciences, Inc. (Nasdaq: KLTO, &#8220;Klotho&#8221;, or &#8220;the Company&#8221;), a U.S.-based biogenetics company, announces that CEO Dr. Joseph Sinkule will be presenting at the 2026 Biotech Showcase in San Francisco on January 13, 2026 at 11:30AM PT.\u00a0 The Biotech Showcase is to be held January 12-14, 2026 at the Hilton San Francisco Union Square. At the event, the Company will be available for one-on-one meetings with investors and potential partners. To request a meeting, please contact ir@klothoneurosciences.com. About Klotho Neurosciences, Inc.\u00a0\u00a0 Klotho Neurosciences, Inc. (NASDAQ:\u00a0KLTO) is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the &#8220;anti-aging&#8221; human &hellip; Continue reading &quot;Klotho Neurosciences to Present at the Biotech Showcase 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-08T13:57:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Klotho Neurosciences to Present at the Biotech Showcase 2026\",\"datePublished\":\"2026-01-08T13:57:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/\"},\"wordCount\":481,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2705840\\\/Klotho_Neurosciences_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/\",\"name\":\"Klotho Neurosciences to Present at the Biotech Showcase 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2705840\\\/Klotho_Neurosciences_Logo.jpg\",\"datePublished\":\"2026-01-08T13:57:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2705840\\\/Klotho_Neurosciences_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2705840\\\/Klotho_Neurosciences_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klotho Neurosciences to Present at the Biotech Showcase 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Klotho Neurosciences to Present at the Biotech Showcase 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/","og_locale":"en_US","og_type":"article","og_title":"Klotho Neurosciences to Present at the Biotech Showcase 2026 - Market Newsdesk","og_description":"PR Newswire NEW YORK, Jan. 8, 2026 \/PRNewswire\/ &#8212;\u00a0Klotho Neurosciences, Inc. (Nasdaq: KLTO, &#8220;Klotho&#8221;, or &#8220;the Company&#8221;), a U.S.-based biogenetics company, announces that CEO Dr. Joseph Sinkule will be presenting at the 2026 Biotech Showcase in San Francisco on January 13, 2026 at 11:30AM PT.\u00a0 The Biotech Showcase is to be held January 12-14, 2026 at the Hilton San Francisco Union Square. At the event, the Company will be available for one-on-one meetings with investors and potential partners. To request a meeting, please contact ir@klothoneurosciences.com. About Klotho Neurosciences, Inc.\u00a0\u00a0 Klotho Neurosciences, Inc. (NASDAQ:\u00a0KLTO) is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the &#8220;anti-aging&#8221; human &hellip; Continue reading \"Klotho Neurosciences to Present at the Biotech Showcase 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-08T13:57:32+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Klotho Neurosciences to Present at the Biotech Showcase 2026","datePublished":"2026-01-08T13:57:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/"},"wordCount":481,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/","name":"Klotho Neurosciences to Present at the Biotech Showcase 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg","datePublished":"2026-01-08T13:57:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2705840\/Klotho_Neurosciences_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klotho-neurosciences-to-present-at-the-biotech-showcase-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Klotho Neurosciences to Present at the Biotech Showcase 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925380"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925380\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}